Susquehanna Fundamental Investments LLC acquired a new position in shares of Omeros Co. (NASDAQ:OMER...
Omeros Co. (NASDAQ:OMER – Get Free Report) has earned an average rating of “Moderate Buy” from the f...
Vanguard Group Inc. lowered its stake in shares of Omeros Co. (NASDAQ:OMER - Free Report) by 3.6% in...
Omeros forms oncology committee to guide development of its AML therapy, which showed strong efficac...